Detailed information for compound 217704

Basic information

Technical information
  • TDR Targets ID: 217704
  • Name: 4-chloro-2-(2-hydroxy-3-phenylphenyl)-1H-indo le-5-carboximidamide
  • MW: 361.824 | Formula: C21H16ClN3O
  • H donors: 3 H acceptors: 1 LogP: 4.57 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: Oc1c(cccc1c1cc2c([nH]1)ccc(c2Cl)C(=N)N)c1ccccc1
  • InChi: 1S/C21H16ClN3O/c22-19-15(21(23)24)9-10-17-16(19)11-18(25-17)14-8-4-7-13(20(14)26)12-5-2-1-3-6-12/h1-11,25-26H,(H3,23,24)
  • InChiKey: JBNZKLCCRJJSKQ-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 4-chloro-2-(2-hydroxy-3-phenyl-phenyl)-1H-indole-5-carboxamidine
  • 4-chloro-2-(2-hydroxy-3-phenylphenyl)-1H-indole-5-carboxamidine
  • 4-chloro-2-(2-hydroxy-3-phenyl-phenyl)-1H-indole-5-carboximidamide

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens protease, serine, 2 (trypsin 2) References
Homo sapiens protease, serine, 1 (trypsin 1) References
Homo sapiens plasminogen activator, tissue Starlite/ChEMBL References
Homo sapiens coagulation factor VII (serum prothrombin conversion accelerator) Starlite/ChEMBL References
Homo sapiens coagulation factor X Starlite/ChEMBL References
Homo sapiens kallikrein B, plasma (Fletcher factor) 1 Starlite/ChEMBL References
Homo sapiens protease, serine, 3 Starlite/ChEMBL References
Homo sapiens plasminogen activator, urokinase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Toxoplasma gondii PAN domain-containing protein Get druggable targets OG5_134971 All targets in OG5_134971
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) Get druggable targets OG5_126639 All targets in OG5_126639
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126639 All targets in OG5_126639
Schistosoma japonicum ko:K09639 transmembrane protease, serine 8, putative Get druggable targets OG5_126639 All targets in OG5_126639
Toxoplasma gondii PAN domain-containing protein Get druggable targets OG5_134971 All targets in OG5_134971
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126639 All targets in OG5_126639
Onchocerca volvulus Get druggable targets OG5_126639 All targets in OG5_126639
Onchocerca volvulus Get druggable targets OG5_126639 All targets in OG5_126639
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) Get druggable targets OG5_126639 All targets in OG5_126639
Brugia malayi Trypsin family protein Get druggable targets OG5_126639 All targets in OG5_126639
Neospora caninum hypothetical protein Get druggable targets OG5_134971 All targets in OG5_134971
Neospora caninum hypothetical protein Get druggable targets OG5_134971 All targets in OG5_134971
Neospora caninum hypothetical protein Get druggable targets OG5_134971 All targets in OG5_134971
Schistosoma japonicum ko:K09639 transmembrane protease, serine 8, putative Get druggable targets OG5_126639 All targets in OG5_126639
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Echinococcus granulosus glycoprotein Antigen 5 coagulation factor VII (serum prothrombin conversion accelerator) 466 aa 384 aa 23.7 %
Brugia malayi Trypsin family protein protease, serine, 1 (trypsin 1) 247 aa 287 aa 21.6 %
Echinococcus granulosus Mastin plasminogen activator, urokinase 414 aa 340 aa 24.4 %
Schistosoma mansoni cercarial elastase (S01 family) protease, serine, 3 261 aa 234 aa 25.2 %
Schistosoma mansoni cercarial elastase (S01 family) protease, serine, 2 (trypsin 2) 247 aa 240 aa 25.8 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Onchocerca volvulus 0.0361 1 1
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.0361 1 0.5
Toxoplasma gondii PAN domain-containing protein 0.0356 0.8881 0.5
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.0361 1 0.5
Loa Loa (eye worm) hypothetical protein 0.0361 1 0.5
Loa Loa (eye worm) hypothetical protein 0.0361 1 0.5
Toxoplasma gondii PAN domain-containing protein 0.0356 0.8881 0.5

Activities

Activity type Activity value Assay description Source Reference
Ki (binding) = 0.49 uM The compound was tested for inhibition of human urokinase type plasminogen activator (microPa) ChEMBL. 11689072
Ki (binding) = 0.49 uM The compound was tested for inhibition of human urokinase type plasminogen activator (microPa) ChEMBL. 11689072
Ki (binding) = 1.3 uM The compound was tested for inhibition of human p-kallikrein ChEMBL. 11689072
Ki (binding) = 1.3 uM The compound was tested for inhibition of human p-kallikrein ChEMBL. 11689072
Ki (binding) = 3 uM The compound was tested for inhibition of human plasmin ChEMBL. 11689072
Ki (binding) = 3 uM The compound was tested for inhibition of human plasmin ChEMBL. 11689072
Ki (binding) = 3.3 uM The compound was tested for inhibition of human tissue plasminogen activator ChEMBL. 11689072
Ki (binding) = 3.3 uM The compound was tested for inhibition of human tissue plasminogen activator ChEMBL. 11689072
Ki (binding) = 4.7 uM The compound was tested for inhibition of human trypsin ChEMBL. 11689072
Ki (binding) = 4.7 uM The compound was tested for inhibition of human trypsin ChEMBL. 11689072
Ki (binding) = 5.2 uM Binding affinity against human coagulation factor X ChEMBL. 11689072
Ki (binding) = 5.2 uM Binding affinity against human coagulation factor X ChEMBL. 11689072
Ki (binding) = 5.5 uM The compound was tested for inhibition of human coagulation factor VII ChEMBL. 11689072
Ki (binding) = 5.5 uM The compound was tested for inhibition of human coagulation factor VII ChEMBL. 11689072
Ki (binding) = 65 uM The compound was tested for inhibition of human thrombin ChEMBL. 11689072
Ki (binding) = 65 uM The compound was tested for inhibition of human thrombin ChEMBL. 11689072

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.